Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
38I:FRA
Intellia Therapeutics Inc
€ 10.84
-12.01%
(-1.48) Siku 1
28 Apr, 08:13:34 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 38I...
Fungua
€ 10.84
Juu
€ 10.84
Chini
€ 10.84
Mtaji wa soko
1.54B
Wastani wa kiasi cha mauzo
198.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 24.34
Chini kwa wiki 52
€ 6.00
Idadi ya wafanyakazi
377
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases. The CRISPR gene editing system was originally invented by Jennifer Doudna, one of Intellia's scientific founders, and Virginijus Šikšnys. The company has entered into a number of different research and development collaborations with leading and emerging biotechnology companies including Novartis, Regeneron, Avencell, SparingVision, Kyverna, and ONK Therapeutics. Intellia has two in vivo programs in ongoing clinical trials. NTLA-2001 is an investigational CRISPR therapy candidate for the treatment for ATTR amyloidosis currently in Phase 1 studies. Wikipedia
Kuhusu Intellia Therapeutics Inc
Afisa Mkuu Mtendaji (CEO)John Leonard
Wafanyakazi377
Lilianzishwa2014
Makao makuuCambridge, Massachusetts, Marekani
Sekta-
Tovutiintelliatx.com
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
16.63M
14.24M
13.78M
23.02M
Gharama ya bidhaa zilizouzwa
108.43M
80.53M
78.95M
73.63M
Gharama ya mapato
108.43M
80.53M
78.95M
73.63M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
29.01M
43.71M
46.31M
48.10M
Gharama ya uendeshaji
29.01M
43.71M
46.31M
48.10M
Jumla ya gharama za uendeshaji
137.43M
124.24M
125.26M
121.73M
Mapato ya uendeshaji
-120.81M
-110.00M
-111.48M
-98.71M
Mapato mengine yasiyo ya uendeshaji
-
-
-
-
EBT ikijumuisha vipengee visivyo vya kawaida
-114.33M
-101.26M
-101.32M
-95.79M
EBT bila kujumuisha vipengee visivyo vya kawaida
-112.20M
-102.59M
-104.76M
-92.23M
Gharama ya kodi ya mapato
-
-
-
-
Kiwango cha kodi kinachotumika
-
-
-
-
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
-114.33M
-101.26M
-101.32M
-95.79M
Kiwango cha faida halisi
-687.61%
-710.81%
-735.19%
-416.15%
Mapato kwa kila hisa
-1.10
-0.98
-0.92
-0.83
Mapato ya riba na uwekezaji
8.60M
7.40M
6.71M
6.48M
Gharama ya riba
-
-
-
-
Jumla ya gharama halisi za riba
8.60M
7.40M
6.71M
6.48M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-118.31M
-107.52M
-109.06M
-96.33M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
elfu 527.00
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho